/Boston%20Scientific%20Corp_%20logo%20on%20iPad-%20by%20Kate%20Krav-Rude%20via%20Shutterstock.jpg)
Based in Marlborough, Massachusetts, Boston Scientific Corporation (BSX) operates in the medical device industry with a market cap of $113.1 billion. The company develops, manufactures, and markets innovative devices for cardiovascular, rhythm and neuro, and MedSurg applications, addressing a wide range of interventional medical needs worldwide.
Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Boston Scientific fits this criterion perfectly, exceeding the mark. Boston Scientific's groundbreaking medical devices, particularly the Taxus drug-eluting stents and the EMBLEM subcutaneous implantable defibrillator (S-ICD), fuel its significant revenue streams and solidify its dominant position in the global medical technology market.